Romosozumab plus alendronate led to a greater improvement in bone strength than alendronate alone in postmenopausal women ...
New research led by experts at the University of Nottingham calls for greater awareness of the symptoms of bone cancers in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback